
Christopher Upton
Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1797, 1306, 1308, 1776, 1778, 1724 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9482783
[patent_doc_number] => 08728733
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-05-20
[patent_title] => 'Methyl-CpG island-associated genome signature tags'
[patent_app_type] => utility
[patent_app_number] => 11/926203
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22447
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11926203
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/926203 | Methyl-CpG island-associated genome signature tags | Oct 28, 2007 | Issued |
Array
(
[id] => 4916207
[patent_doc_number] => 20080096808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'USE OF RAPAMYCIN TO INHIBIT RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 11/924949
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7320
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096808.pdf
[firstpage_image] =>[orig_patent_app_number] => 11924949
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/924949 | USE OF RAPAMYCIN TO INHIBIT RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS | Oct 25, 2007 | Abandoned |
Array
(
[id] => 4898907
[patent_doc_number] => 20080118521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'GENE EXPRESSION ASSOCIATED WITH OSTEOBLAST DIFFERENTIATION'
[patent_app_type] => utility
[patent_app_number] => 11/924367
[patent_app_country] => US
[patent_app_date] => 2007-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23606
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20080118521.pdf
[firstpage_image] =>[orig_patent_app_number] => 11924367
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/924367 | GENE EXPRESSION ASSOCIATED WITH OSTEOBLAST DIFFERENTIATION | Oct 24, 2007 | Abandoned |
Array
(
[id] => 5422413
[patent_doc_number] => 20090148868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'JAB1 AS A PROGNOSTIC MARKER AND A THERAPEUTIC TARGET FOR HUMAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/874838
[patent_app_country] => US
[patent_app_date] => 2007-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 38601
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11874838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/874838 | JAB1 as a prognostic marker and a therapeutic target for human cancer | Oct 17, 2007 | Issued |
Array
(
[id] => 5480031
[patent_doc_number] => 20090202988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Trap vectors and gene trapping using the same'
[patent_app_type] => utility
[patent_app_number] => 11/907497
[patent_app_country] => US
[patent_app_date] => 2007-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11569
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202988.pdf
[firstpage_image] =>[orig_patent_app_number] => 11907497
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/907497 | Trap vectors and gene trapping using the same | Oct 11, 2007 | Abandoned |
Array
(
[id] => 6248555
[patent_doc_number] => 20100137161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => ' METHOD OF GENERATING A PLATELET REACTIVITY PROFILE FOR AN INDIVIDUAL'
[patent_app_type] => utility
[patent_app_number] => 12/444480
[patent_app_country] => US
[patent_app_date] => 2007-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6439
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137161.pdf
[firstpage_image] =>[orig_patent_app_number] => 12444480
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/444480 | METHOD OF GENERATING A PLATELET REACTIVITY PROFILE FOR AN INDIVIDUAL | Oct 7, 2007 | Abandoned |
Array
(
[id] => 6485066
[patent_doc_number] => 20100092958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Methods for Determining Collateral Artery Development in Coronary Artery Disease'
[patent_app_type] => utility
[patent_app_number] => 12/444423
[patent_app_country] => US
[patent_app_date] => 2007-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9876
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20100092958.pdf
[firstpage_image] =>[orig_patent_app_number] => 12444423
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/444423 | Methods for Determining Collateral Artery Development in Coronary Artery Disease | Oct 4, 2007 | Abandoned |
Array
(
[id] => 5452617
[patent_doc_number] => 20090068654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'ASSAY FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF MRNA'
[patent_app_type] => utility
[patent_app_number] => 11/868397
[patent_app_country] => US
[patent_app_date] => 2007-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 17262
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068654.pdf
[firstpage_image] =>[orig_patent_app_number] => 11868397
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/868397 | ASSAY FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF MRNA | Oct 4, 2007 | Abandoned |
Array
(
[id] => 5485277
[patent_doc_number] => 20090275042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Method of Detecting and/or Quantifying Expression of a Target Protein Candidate in a Cell, and a Method of Identifying a Target Protein of a Small Molecule Modulator'
[patent_app_type] => utility
[patent_app_number] => 12/439422
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10074
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12439422
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/439422 | Method of Detecting and/or Quantifying Expression of a Target Protein Candidate in a Cell, and a Method of Identifying a Target Protein of a Small Molecule Modulator | Sep 19, 2007 | Abandoned |
Array
(
[id] => 5403921
[patent_doc_number] => 20090239235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => ' Facs- and Reporter Protein-Based System for High Throughput Development of Therapeutic Proteins'
[patent_app_type] => utility
[patent_app_number] => 12/441806
[patent_app_country] => US
[patent_app_date] => 2007-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12191
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239235.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441806
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441806 | Facs- and Reporter Protein-Based System for High Throughput Development of Therapeutic Proteins | Sep 17, 2007 | Abandoned |
Array
(
[id] => 4932832
[patent_doc_number] => 20080003607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'METHODS TO IDENTIFY POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES WHICH MAY BE ASSOCIATED WITH PHYSIOLOGICAL AND MEDICAL CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/781818
[patent_app_country] => US
[patent_app_date] => 2007-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 38023
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003607.pdf
[firstpage_image] =>[orig_patent_app_number] => 11781818
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/781818 | METHODS TO IDENTIFY POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES WHICH MAY BE ASSOCIATED WITH PHYSIOLOGICAL AND MEDICAL CONDITIONS | Sep 11, 2007 | Abandoned |
Array
(
[id] => 5569789
[patent_doc_number] => 20090253167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'Methanol-responsive promoter, fusion gene comprising promoter and foreign gene connected so that foreign gene can be expressed, vector, transformant, and method of producing protein'
[patent_app_type] => utility
[patent_app_number] => 11/853536
[patent_app_country] => US
[patent_app_date] => 2007-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6655
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253167.pdf
[firstpage_image] =>[orig_patent_app_number] => 11853536
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/853536 | Methanol-responsive promoter, fusion gene comprising promoter and foreign gene connected so that foreign gene can be expressed, vector, transformant, and method of producing protein | Sep 10, 2007 | Abandoned |
Array
(
[id] => 4892972
[patent_doc_number] => 20080102070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'SCDs As Modifiers of the p53 Pathway and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 11/852890
[patent_app_country] => US
[patent_app_date] => 2007-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16628
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20080102070.pdf
[firstpage_image] =>[orig_patent_app_number] => 11852890
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/852890 | SCDs As Modifiers of the p53 Pathway and Methods of Use | Sep 9, 2007 | Abandoned |
Array
(
[id] => 10097192
[patent_doc_number] => 09133495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Hybrid suppressor tRNA for vertebrate cells'
[patent_app_type] => utility
[patent_app_number] => 12/440015
[patent_app_country] => US
[patent_app_date] => 2007-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 37976
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12440015
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/440015 | Hybrid suppressor tRNA for vertebrate cells | Sep 6, 2007 | Issued |
Array
(
[id] => 32316
[patent_doc_number] => 07790449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-07
[patent_title] => 'Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/899500
[patent_app_country] => US
[patent_app_date] => 2007-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21520
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/790/07790449.pdf
[firstpage_image] =>[orig_patent_app_number] => 11899500
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/899500 | Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor | Sep 5, 2007 | Issued |
Array
(
[id] => 5508576
[patent_doc_number] => 20090081783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Method for producing langerhans cells or interstitial dendritic cells or both from CD14+ monocytes'
[patent_app_type] => utility
[patent_app_number] => 11/897617
[patent_app_country] => US
[patent_app_date] => 2007-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10571
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081783.pdf
[firstpage_image] =>[orig_patent_app_number] => 11897617
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/897617 | Method for producing langerhans cells or interstitial dendritic cells or both from CD14+ monocytes | Aug 31, 2007 | Abandoned |
Array
(
[id] => 6231196
[patent_doc_number] => 20100184610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'METHOD OF PROGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/439350
[patent_app_country] => US
[patent_app_date] => 2007-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16327
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184610.pdf
[firstpage_image] =>[orig_patent_app_number] => 12439350
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/439350 | METHOD OF PROGNOSIS | Aug 27, 2007 | Abandoned |
Array
(
[id] => 4555282
[patent_doc_number] => 07842290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-30
[patent_title] => 'Identification of genes'
[patent_app_type] => utility
[patent_app_number] => 11/840903
[patent_app_country] => US
[patent_app_date] => 2007-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 112
[patent_figures_cnt] => 117
[patent_no_of_words] => 23241
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842290.pdf
[firstpage_image] =>[orig_patent_app_number] => 11840903
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/840903 | Identification of genes | Aug 16, 2007 | Issued |
Array
(
[id] => 4939516
[patent_doc_number] => 20080076835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'METHODS OF MODULATING MITOCHONDRIAL NAD-DEPENDENT DEACETYLASE'
[patent_app_type] => utility
[patent_app_number] => 11/839292
[patent_app_country] => US
[patent_app_date] => 2007-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18897
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076835.pdf
[firstpage_image] =>[orig_patent_app_number] => 11839292
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/839292 | METHODS OF MODULATING MITOCHONDRIAL NAD-DEPENDENT DEACETYLASE | Aug 14, 2007 | Abandoned |
Array
(
[id] => 9140480
[patent_doc_number] => 08580941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'Epididymal lipocalin gene and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/890842
[patent_app_country] => US
[patent_app_date] => 2007-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 26
[patent_no_of_words] => 24877
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11890842
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/890842 | Epididymal lipocalin gene and uses thereof | Aug 7, 2007 | Issued |